Mr Byron R Mendenhall, MD | |
400 W Mineral King, Visalia, CA 93291 | |
(559) 624-2000 | |
Not Available |
Full Name | Mr Byron R Mendenhall |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 400 W Mineral King, Visalia, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932155769 | NPI | - | NPPES |
00A415550 | Other | CA | BS OF CA |
00A415550 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | A41555 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Byron R Mendenhall, MD Po Box 7096, Stockton, CA 95267-0096 Ph: (209) 956-7725 | Mr Byron R Mendenhall, MD 400 W Mineral King, Visalia, CA 93291 Ph: (559) 624-2000 |
News Archive
The European Liver Patients Association (ELPA) and the World Hepatitis Alliance (WHA), announced today on the 4th annual World Hepatitis Day that 'PATH B - "Patients and Professionals Acting Together for Hepatitis B" - My journey with chronic hepatitis B', a comprehensive educational resource designed to improve the lives of people living with chronic hepatitis B, is to be launched in August 2011.
"Malawi's new president, Joyce Banda, has inherited an unenviable to-do list from former president Bingu wa Mutharika, and AIDS activists are hoping that bolstering the donor-dependent AIDS response will be one of her most urgent priorities," PlusNews reports.
Brazilian textile companies have begun producing and marketing fabrics treated with silver and silica nanoparticles developed by the research groups at the Centre for Functional Materials (CDMF) and the Theoretical and Computational Chemistry Laboratory (QTC) at the Universitat Jaume I, in collaboration with the company Nanox Tecnologia, which provide the new fabrics with antibacterial, antifungal and antiviral properties with 99.99% effectiveness.
Antibiotic resistance poses a grave challenge to many previously curable infectious diseases. At present, antibiotic resistance is proving to increase at a much faster rate compared to the development of new therapies.
Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.
› Verified 5 days ago
Dr. Siva Venu Natarajan, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 3105 W Perez Ave, Visalia, CA 93291 Phone: 310-422-6851 | |
Mr. Todd A Gibbs, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 842 S Akers St, Visalia, CA 93277 Phone: 559-740-4094 Fax: 559-740-4100 | |
Mr. Carlos Huanes, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 842 S Akers St, Visalia, CA 93277 Phone: 559-740-4094 Fax: 559-740-4100 | |
Dr. Bradlee J. Bachar, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2000 | |
Calvin Nguyen-ho, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2000 | |
Michael-dennis Fiss, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2828 W Main St, Visalia, CA 93291 Phone: 559-734-7272 | |
Bruce H Graham, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 842 S. Akers Street, Visalia, CA 93277 Phone: 559-740-4094 Fax: 559-740-4100 |